The site is undergoing maintenance on
Thursday, September 10, 8:00 pm through Friday, September 11, 8:00 pm (EDT), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance on
Thursday, September 10, 8:00 pm through Friday, September 11, 8:00 pm (EDT), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance on
Thursday, September 10, 8:00 pm through Friday, September 11, 8:00 pm (EDT), 2026
.If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
Looks like you're visiting us from {countryName}.
Would you like to stay on the current country site or be switched to your country?
Flow cytometric analysis of human ILT5 (CD85a) expression on human peripheral blood leucocytes. Human whole blood was stained with either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; Left Panel) or Alexa Fluor® 647 Mouse Anti-Human ILT5 (CD85a) antibody (Cat. No. 564469; Right Panel). Erythrocytes were then lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Flow cytometric contour plots showing the correlated expression patterns of ILT5 (CD85a) [or Ig Isotype control staining] versus side scattered-light (SSC) characteristics were generated from gated events with the forward and side light-scatter characteristics of viable leukocytes. Flow cytometric analysis was performed using a BD FACSCanto™ II Flow Cytometer System.
Flow cytometric analysis of human ILT5 (CD85a) expression on human peripheral blood leucocytes. Human whole blood was stained with either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; Left Panel) or Alexa Fluor® 647 Mouse Anti-Human ILT5 (CD85a) antibody (Cat. No. 564469; Right Panel). Erythrocytes were then lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Flow cytometric contour plots showing the correlated expression patterns of ILT5 (CD85a) [or Ig Isotype control staining] versus side scattered-light (SSC) characteristics were generated from gated events with the forward and side light-scatter characteristics of viable leukocytes. Flow cytometric analysis was performed using a BD FACSCanto™ II Flow Cytometer System.
Flow cytometric analysis of human ILT5 (CD85a) expression on human peripheral blood leucocytes. Human whole blood was stained with either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; Left Panel) or Alexa Fluor® 647 Mouse Anti-Human ILT5 (CD85a) antibody (Cat. No. 564469; Right Panel). Erythrocytes were then lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Flow cytometric contour plots showing the correlated expression patterns of ILT5 (CD85a) [or Ig Isotype control staining] versus side scattered-light (SSC) characteristics were generated from gated events with the forward and side light-scatter characteristics of viable leukocytes. Flow cytometric analysis was performed using a BD FACSCanto™ II Flow Cytometer System.
Flow cytometric analysis of human ILT5 (CD85a) expression on human peripheral blood leucocytes. Human whole blood was stained with either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; Left Panel) or Alexa Fluor® 647 Mouse Anti-Human ILT5 (CD85a) antibody (Cat. No. 564469; Right Panel). Erythrocytes were then lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Flow cytometric contour plots showing the correlated expression patterns of ILT5 (CD85a) [or Ig Isotype control staining] versus side scattered-light (SSC) characteristics were generated from gated events with the forward and side light-scatter characteristics of viable leukocytes. Flow cytometric analysis was performed using a BD FACSCanto™ II Flow Cytometer System.
Flow cytometric analysis of human ILT5 (CD85a) expression on human peripheral blood leucocytes. Human whole blood was stained with either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; Left Panel) or Alexa Fluor® 647 Mouse Anti-Human ILT5 (CD85a) antibody (Cat. No. 564469; Right Panel). Erythrocytes were then lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Flow cytometric contour plots showing the correlated expression patterns of ILT5 (CD85a) [or Ig Isotype control staining] versus side scattered-light (SSC) characteristics were generated from gated events with the forward and side light-scatter characteristics of viable leukocytes. Flow cytometric analysis was performed using a BD FACSCanto™ II Flow Cytometer System.
Flow cytometric analysis of human ILT5 (CD85a) expression on human peripheral blood leucocytes. Human whole blood was stained with either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; Left Panel) or Alexa Fluor® 647 Mouse Anti-Human ILT5 (CD85a) antibody (Cat. No. 564469; Right Panel). Erythrocytes were then lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Flow cytometric contour plots showing the correlated expression patterns of ILT5 (CD85a) [or Ig Isotype control staining] versus side scattered-light (SSC) characteristics were generated from gated events with the forward and side light-scatter characteristics of viable leukocytes. Flow cytometric analysis was performed using a BD FACSCanto™ II Flow Cytometer System.
Flow cytometric analysis of human ILT5 (CD85a) expression on human peripheral blood leucocytes. Human whole blood was stained with either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; Left Panel) or Alexa Fluor® 647 Mouse Anti-Human ILT5 (CD85a) antibody (Cat. No. 564469; Right Panel). Erythrocytes were then lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Flow cytometric contour plots showing the correlated expression patterns of ILT5 (CD85a) [or Ig Isotype control staining] versus side scattered-light (SSC) characteristics were generated from gated events with the forward and side light-scatter characteristics of viable leukocytes. Flow cytometric analysis was performed using a BD FACSCanto™ II Flow Cytometer System.
Flow cytometric analysis of human ILT5 (CD85a) expression on human peripheral blood leucocytes. Human whole blood was stained with either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; Left Panel) or Alexa Fluor® 647 Mouse Anti-Human ILT5 (CD85a) antibody (Cat. No. 564469; Right Panel). Erythrocytes were then lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Flow cytometric contour plots showing the correlated expression patterns of ILT5 (CD85a) [or Ig Isotype control staining] versus side scattered-light (SSC) characteristics were generated from gated events with the forward and side light-scatter characteristics of viable leukocytes. Flow cytometric analysis was performed using a BD FACSCanto™ II Flow Cytometer System.
Flow cytometric analysis of human ILT5 (CD85a) expression on human peripheral blood leucocytes. Human whole blood was stained with either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; Left Panel) or Alexa Fluor® 647 Mouse Anti-Human ILT5 (CD85a) antibody (Cat. No. 564469; Right Panel). Erythrocytes were then lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Flow cytometric contour plots showing the correlated expression patterns of ILT5 (CD85a) [or Ig Isotype control staining] versus side scattered-light (SSC) characteristics were generated from gated events with the forward and side light-scatter characteristics of viable leukocytes. Flow cytometric analysis was performed using a BD FACSCanto™ II Flow Cytometer System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The 222821 monoclonal antibody specifically binds to Immunoglobulin-like transcript 5 (ILT5) which is also known as CD85a (CD85 antigen-like family member A), Leukocyte immunoglobulin-like receptor 3 (LIR-3), and Monocyte inhibitory receptor HL9. ILT5 is encoded by LILRB3 and belongs to the ILT/LTR family in the Ig gene superfamily. ILT5 is expressed by a variety of cell types including monocytes, macrophages, granulocytes, NK cells, osteoclast precursors, and a subset of T lymphocytes. This transmembrane receptor contains intracellular immunoreceptor tyrosine based inhibitory motifs (ITIMs) that can inhibit intracellular signaling. ILT5 can bind to MHC Class I molecules and appears to be involved in regulating immune responses such as NK cell-mediated cytotoxicity.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.